Treatments for obesity remain limited and with low success. Current therapies do not account for known differences in individual obesity susceptibility, which might be key for developing successful treatments. Susceptibility and severity to obesity are linked to individual differences in spontaneous physical activity (SPA). Our long-term goal is to provide the biological basis for development of personalized obesity therapies. To do this, we will use a novel model of differential susceptibility to obesity, the hig activity (HA) and low activity (LA) rats. HA rats are obesity resistant and higher signaling by orexin peptides than LA rats. The orexins are key modulators of SPA and energy balance. Our overall goal is to define the mechanisms underlying orexin involvement in to SPA and their relevance to obesity susceptibility in the HA/LA rat model. A long-standing hypothesis about the orexins is their functional specialization, which proposes that orexin neurons in the lateral hypothalamus (LH) mediate reward, while neurons in the perifornical area (PeF) and dorsomedial hypothalamus (DMH) mediate arousal.
Aim 1 will determine which orexin neuron subpopulations (LH or PeF/DMH) are more relevant for the HA/LA phenotype. We will knock- down and over-express orexins in these areas to test their necessity or sufficiency for SPA in. Next, we will focus on orexin signaling through rostral LH (rLH). This pathway mediates increases in SPA and may be key for expression of the HA phenotype.
Aim 2 will determine the relevance of rLH orexin signaling to obesity susceptibility in HA/LA rats. We will determine how obesity affects orexin rLH signaling in HA/LA rats and if blocking orexin responses in rLH increases obesity susceptibility in HA rats. Next, we will study interactions between rLH and nucleus accumbens shell (NAcSh). NAcSh interacts with orexin neurons to affect feeding and SPA. Inhibition of NAcSh GABAergic efferents increases SPA caused by orexin injection in rLH in LA, but not in HA rats.
Aim 3 will study NAcSh and rLH interactions in the HA/LA phenotype. We will determine if there is a combined effect of rLH and NAcSh orexin signaling in HA rats, whether feeding responses after manipulation of NAcSh are different between HA/LA rats and define the neuroanatomical connections between NAcSh and rLH orexin-responsive neurons. These studies will fill the gap in knowledge of orexin neural circuitry in mediating phenotypic differences between HA and LA rats, which will improve our understanding of brain mechanisms underlying individual obesity susceptibility and enhance therapeutic approaches to obesity.

Public Health Relevance

Current obesity therapies do not account for large differences in individual obesity susceptibility, but such differences may be key to developing successful treatments. This proposal's broad, long-term objectives are to advance our understanding of individual obesity susceptibility. To do this, a new model of differential susceptibility to obesit, the recently described high activity (HA) and low activity (LA) rat model will be used. HA/LA rats are selected based only on their intrinsic propensity for movement. HA rats have higher activity energy expenditure and are more resistant to obesity compared to LA rats, and show differential responses to brain orexin injection. We will perform behavioral and biochemical assays using this rat model to understand the role of the neuropeptide orexin in the hypothalamus, and its interaction with other reward-related brain areas. The information from these studies will be informative for the development of new, individually targeted obesity therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK100281-02
Application #
8811939
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Hyde, James F
Project Start
2014-03-01
Project End
2018-02-28
Budget Start
2015-03-01
Budget End
2016-02-29
Support Year
2
Fiscal Year
2015
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Nutrition
Type
Earth Sciences/Resources
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Zink, A N; Bunney, P E; Holm, A A et al. (2018) Neuromodulation of orexin neurons reduces diet-induced adiposity. Int J Obes (Lond) 42:737-745
Kotz, Catherine M; Perez-Leighton, Claudio E; Teske, Jennifer A et al. (2017) Spontaneous Physical Activity Defends Against Obesity. Curr Obes Rep 6:362-370
Perez-Leighton, Claudio; Little, Morgan R; Grace, Martha et al. (2017) Orexin signaling in rostral lateral hypothalamus and nucleus accumbens shell in the control of spontaneous physical activity in high- and low-activity rats. Am J Physiol Regul Integr Comp Physiol 312:R338-R346
Mavanji, Vijayakumar; Butterick, Tammy A; Duffy, Cayla M et al. (2017) Orexin/hypocretin treatment restores hippocampal-dependent memory in orexin-deficient mice. Neurobiol Learn Mem 146:21-30
Coborn, J E; DePorter, D P; Mavanji, V et al. (2017) Role of orexin-A in the ventrolateral preoptic area on components of total energy expenditure. Int J Obes (Lond) 41:1256-1262
Bunney, P E; Zink, A N; Holm, A A et al. (2017) Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet. Physiol Behav 176:139-148
Mavanji, Vijayakumar; Perez-Leighton, Claudio E; Kotz, Catherine M et al. (2015) Promotion of Wakefulness and Energy Expenditure by Orexin-A in the Ventrolateral Preoptic Area. Sleep 38:1361-70
Duffy, Cayla M; Yuan, Ce; Wisdorf, Lauren E et al. (2015) Role of orexin A signaling in dietary palmitic acid-activated microglial cells. Neurosci Lett 606:140-4
Nixon, Joshua P; Mavanji, Vijayakumar; Butterick, Tammy A et al. (2015) Sleep disorders, obesity, and aging: the role of orexin. Ageing Res Rev 20:63-73
Perez-Leighton, Claudio E; Grace, Martha; Billington, Charles J et al. (2014) Role of spontaneous physical activity in prediction of susceptibility to activity based anorexia in male and female rats. Physiol Behav 135:104-11